With plans of creeping in share acquisition, promoters of Elder Pharmaceuticals have entered in talks with some Japanese companies to supply bulk drugs. The company would start marketing the products in Japan in the next three to four months.
The pharma major recently received an accreditation from the Ministry of Health, Japan for their API plant in Maharashtra. Talking to CNBC-TV18, director Alok Saxena said that the accreditation would help enter grow in the Japanese pharma market.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.